Trade

with

Stereotaxis Inc
(NASDAQ: STXS)
AdChoices
1.93
+0.05
+2.66%
After Hours :
1.90
-0.03
-1.55%

Open

1.92

Previous Close

1.88

Volume (Avg)

83.77k (123.78k)

Day's Range

1.86-1.93

52Wk Range

1.82-6.34

Market Cap.

39.10M

Dividend Rate ( Yield )

-

Beta

3.16

Shares Outstanding

20.26M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 38.03M

    • Net Income

    • -68.76M

    • Market Cap.

    • 39.10M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -184.37

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 3.16

    • Forward P/E

    • -

    • Price/Sales

    • 0.92

    • Price/Book Value

    • -2.66

    • Price/Cash flow

    • -3.88

      • EBITDA

      • -54.97M

      • Return on Capital %

      • -260.96

      • Return on Equity %

      • -

      • Return on Assets %

      • -260.96

      • Book Value/Share

      • -0.73

      • Shares Outstanding

      • 20.26M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -17.30

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -

          • -15.59

          • Net Income

            Q/Q (last year)

          • -

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • -1.18

          • 12.51

          • Net Income

            5-Year Annual Average

          • -

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 72.61

            • 52.83

            • Pre-Tax Margin

            • -184.37

            • 15.96

            • Net Profit Margin

            • -184.37

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 69.50

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • -73.50

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 1.07

              • 1.97

              • Quick Ratio

              • 0.77

              • 1.16

              • Interest Coverage

              • -5.58

              • 10.47

              • Leverage Ratio

              • -

              • 2.38

              • Book Value/Share

              • -0.73

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -0.49

                • 34.60

                • P/E Ratio 5-Year High

                • -14.56

                • 279.76

                • P/E Ratio 5-Year Low

                • -0.24

                • 148.87

                • Price/Sales Ratio

                • 0.91

                • 3.21

                • Price/Book Value

                • -2.63

                • 4.00

                • Price/Cash Flow Ratio

                • -3.88

                • 16.67

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -

                        (-)

                      • 17.93

                        (21.42)

                      • Return on Assets %

                        (5-Year Average)

                      • -260.96

                        (-76.80)

                      • 7.35

                        (9.50)

                      • Return on Capital %

                        (5-Year Average)

                      • -

                        (-)

                      • 10.24

                        (13.59)

                      • Income/Employee

                      • -

                      • 25.65k

                      • Inventory Turnover

                      • 1.71

                      • 2.66

                      • Asset Turnover

                      • 1.42

                      • 0.59

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -8.84M
                      Operating Margin
                      -23.25
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -3.88
                      Ownership

                      Institutional Ownership

                      21.06%

                      Top 10 Institutions

                      20.25%

                      Mutual Fund Ownership

                      4.15%

                      Float

                      84.50%

                      5% / Insider Ownership

                      9.62%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Total Stock Mkt Idx

                      •  

                        258,680

                      • 0.00

                      • 1.28

                      • Vanguard Extended Market Index Fund

                      •  

                        146,937

                      • 0.82

                      • 0.73

                      • Balaguer 98 de Inversiones SICAV

                      •  

                        117,915

                      • -1.73

                      • 0.59

                      • Inver-99 SICAV

                      •  

                        117,915

                      • -1.73

                      • 0.59

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        64,951

                      • 0.00

                      • 0.32

                      • AQR Small Cap Momentum Fund

                      •  

                        38,200

                      • -7.73

                      • 0.19

                      • Lempira SICAV

                      •  

                        20,020

                      • -0.16

                      • 0.10

                      • Vanguard Balanced Index Fund

                      •  

                        16,212

                      • 0.00

                      • 0.08

                      • DFA U.S. Micro Cap Portfolio

                      •  

                        10,471

                      • 0.00

                      • 0.05

                      • DFA U.S. Small Cap Portfolio

                      •  

                        8,630

                      • 0.00

                      • 0.04

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Dafna Capital Management LLC

                      •  

                        1,381,460

                      • 0.00%

                      • 6.83

                      • BlackRock Fund Advisors

                      •  

                        739,990

                      • +5.04%

                      • 3.66

                      • Franklin Advisers, Inc.

                      •  

                        672,852

                      • -31.76%

                      • 4.60

                      • Vanguard Group, Inc.

                      •  

                        401,461

                      • 0.00%

                      • 1.99

                      • Gesiuris Asset Management SGIIC

                      •  

                        235,830

                      • -1.73%

                      • 1.18

                      • GMT Capital Corp

                      •  

                        127,481

                      • 0.00%

                      • 0.63

                      • Geode Capital Management, LLC

                      •  

                        71,008

                      • -0.02%

                      • 0.35

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Instruments & Supplies

                      Type

                      Slow Growth

                      Style

                      Small Value

                      Stereotaxis Inc was incorporated in Delaware on June 1990. The Company designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital’s interventional surgical suite to enhance the treatment ...moreof arrhythmias and coronary artery disease. The Niobe system is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, efficient procedures and reduced x-ray exposure. The core components of the Niobe system have received regulatory clearance in the U....moreS., Canada Europe, and various other countries. In addition to the Niobe system and its components, the Company also has developed the Odyssey Solution, which consolidates the multiple sources of diagnostic and imaging information found in the interventional lab into a large-screen user interface with single mouse control, which could be connected via a private network line to other interventional labs or to a remote clinical call center. The system also features a remote viewing and recording capability, called Odyssey Cinema, which simultaneously captures procedure data from multiple sources. The tool includes an archiving capability that would allow clinicians to store and replay entire procedures or segments of procedures. This information could be accessed from locations throughout the hospital local area network and over the global Odyssey network providing physicians with a tool for clinical collaboration, remote consultation and training. The Company operates mainly in the U.S., Europe and Asia and it continues to sell its products both within and outside of the U.S. It markets its products in the U.S and internationally through a direct sales force of senior sales specialists, distributors and sales agents, supported by account managers and clinical specialists that provide training, clinical support, and other services to its customers. The markets for medical devices are intensely competitive and are characterized by rapid technological advances, frequent new product introductions, evolving industry standards and price erosion. It faces competition from companies that are developing new approaches and products for use in interventional procedures, including robotic approaches that are directly competitive with its technology. It also faces competition from companies who currently market or are developing drugs, gene or cellular therapies to treat the conditions for which the Company’s products are intended.lessless

                      Key People

                      Mr. William C. Mills,III

                      CEO/Chairman of the Board/Director

                      Mr. Martin C. Stammer

                      CFO/Chief Accounting Officer

                      David Giffin

                      Vice President, Divisional

                      David W. Benfer

                      Director

                      Dr. Eric N. Prystowsky,M.D.

                      Director

                      • Stereotaxis Inc

                      • 4320 Forest Park Avenue

                      • St. Louis, MO 63108

                      • USA.Map

                      • Phone: +1 314 678-6100

                      • Fax: +1 314 678-6159

                      • stereotaxis.com

                      Incorporated

                      1990

                      Employees

                      123

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: